Exact Sciences Plans Public Stock Offering

EXACT Sciences Q1 13 Earnings Conference Call At 10:00 AM ET

Exact Sciences: Cologuard Colorectal Cancer Screening Test Met Primary Endpoints

In The Spotlight: Exact Sciences Corp

EXACT Sciences To Present At Citi Healthcare Conference; Webcast At 11:05 AM ET

Trade EXAS now with

8/8/2012 5:58 AM ET

Exact Sciences Corp.(EXAS: Quote),a molecular diagnostics company focusing on the early detection of colorectal cancer, Tuesday said that it had decided to sell its common stock shares through an under written public offering. The company, however did not disclose the size or price of the offering.

Jefferies & Company, Inc. and Robert W. Baird & Co. Inc. are acting as joint book-running managers for the offering, said Exact Sciences.

On Tuesday, Exact Sciences Corp closed at $10.29 per share on the NASDAQ.

Click here to receive FREE breaking news email alerts for EXACT Sciences Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

More Breaking News

<<Previous 64 Articles

Editors Pick

Autodesk Results Miss Estimates; Cuts Outlook

Design software maker Autodesk, Inc. (ADSK) Thursday reported a 30 percent decline in earnings from last year, hurt by lower revenue and weaker margins. The company's quarterly earnings per share, excluding items, came in below analysts' expectations as did its quarterly revenue. At the same time,...

Dell Profit Drops 79% On Sluggish PC Demand

Struggling PC maker Dell Inc. said Thursday after the markets closed that its first quarter profit dropped 79% from last year, as revenue declined and margins deteriorated amid sluggish demand for personal computers. The company's quarterly earnings per share, excluding items, also came in way below analysts' expectations, but its quarterly revenue beat analysts' forecast.

Cisco Results Top Estimates

Cisco Systems, Inc., the world's largest computer networking gear maker, said Wednesday after the markets closed that its third quarter profit rose 14.5% from last year, helped by higher sales and a tax benefit. The company's quarterly earnings per share, excluding items, also came in above analysts' expectations as did its quarterly sales.